Diabetes Mellitus Type 2 DM (NIDDM) Not merely “ SUGAR DISORDER” Multi system disease – A syndrome Metabolic – endocrine – vascular – –Cardiac – cerebral.

Slides:



Advertisements
Similar presentations
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Advertisements

Endocrine Module 1b. Pancreas Gland 6 ” long Horizontal Behind stomach Upper left abdominal quadrant Both endocrine & exocrine functions.
DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference Circulation. 2004;109:
Islets of Langerhan. Prof. K. Sivapalan Islets of Langerhan2 Histology. A cells 20 % [glucogon] B cells 50% [Insulin] D cells 8% [somatostatin]
Diabetes Mellitus.
Diabetes and Aging MCB 135K Laura Epstein 4/14/06.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Metabolic Syndrome Jacque De Fouw RN, MSN Health Educator.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Understanding blood lipids and glucose How a Healthy Lifestyle can improve your numbers Susan Fullmer, PhD RD Associate Teaching Professor Nutrition, Dietetics,
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
What is Diabetes?.
Absorptive (fed) state
CONTROLLING CARBS AND PREVENTING DISEASE Low carb, obesity, cardiovascular disease and diabetes Jacqueline A. Eberstein, R.N.
DIABETES MELLITUS DR. J. PRATHEEBA DEVI. Definition Definition Diabetes is a metabolic disorder characterized by raised levels of glucose in the blood.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Interactions between the Liver and Pancreas. Explain the control of blood glucose concentration, including the roles of glucagon, insulin and α and β.
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
Adult Medical-Surgical Nursing
METABOLIC Syndrome: a Global Perspective
Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.
DIABETES MILLITUS AND COMPLICATION
Chapter 5 Type 2 diabetes. Chapter overview Introduction Aetiology Prevalence Obesity as a risk factor Physical inactivity as a risk factor Low physical.
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
Diabetes Mellitus (Lecture 2). Type 2 DM 90% of diabetics (in USA) Develops gradually may be without obvious symptoms may be detected by routine screening.
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
Reem Sallam, MD, MSc. PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Dr. Amr S. Moustafa, MD, PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Hypertension, Cardiovascular Disease, Diabetes. 34% of Americans 36% of Americans.
Regulating Blood Sugar Islets of Langerhans groups of cells in the pancreas beta cells produce insulin alpha cells produce glucagon.
Regulation of insulin levels Starter: what do each of the following cells produce and are they part of the endocrine or exocrine system; –α cells –β cells.
Diabetes National Diabetes Control Programme
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Obesity and Endocrine Disorders Dr EM Selepe MBChB(Natal) FCA(SA) 1 Military Hospital Thaba Tshwane 1.
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
Prevention of complications of endocrine disorders R.Fielding Department of Community Medicine, HKU.
Dr. Nathasha Luke.  Define the term glucose homeostasis  Describe how blood glucose levels are maintained in the fasting state and fed state  Describe.
Epidemiology and Diagnosis A Practical Guide to Therapy Monotherapy Combination Therapy Add ons.
Diabetes Mellitus Type 2
Prevention of Diabetes, Can we?. EP Joslin, 1921 “…… it is proper at the present time to devote time not alone to treatment, but still more, as in the.
Chapter Exercise and Diabetes Dixie L. Thompson C H A P T E R.
LAB (6): LIPIDS PROFILE KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2013.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
นพ. เฉลิมศักดิ์ สุวิชัย โรงพยาบาล พะเยา. Management of Type 2 Diabetes Mellitus: A New Paradigm Approach Dr. Chalermsak Suwichai Phayao Hospital.
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
Is NIDDM really a CAD Equivalent ? How to assess CV risk in NIDDM ? Dharma Vira Heart Center Sir Ganga Ram Hospital New Delhi , India.
OPD follow up 1. General P/E Blood pressure Sites of insulin injection Deep tendon reflex 2.
What is Diabetes? Definition: A disorder of metabolism where the pancreas produces little or no insulin or the cells do not respond to the insulin produced.
Exercise & DM In the Name of God Dr. Laleh Hakemi, Internist
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Chapter 5 Type 2 diabetes.
Integration of Metabolism
Endocrine Block 1 Lecture Dr. Usman Ghani
Endocrine Block Dr. Usman Ghani
Chapter 7 Metabolic syndrome
Diabetes Mellitus Nursing Management.
Metabolic Changes in Diabetes Mellitus
Endocrine Block 1 Lecture Dr. Usman Ghani
Metabolic Changes in Diabetes Mellitus
Regulating Blood Sugar
Diabetes Mellitus.
Diabetes Health Status Report
Information I’ll assume that you know:
برنامه غربالگری و بیماریابی بیماری های قلبی عروقی و عوامل خطر آن در استان فارس معاونت بهداشتی دانشگاه علوم پزشکی شیراز واحد غیر واگیر برنامه قلب و عروق.
Screening and Monitoring
Presentation transcript:

Diabetes Mellitus Type 2 DM (NIDDM) Not merely “ SUGAR DISORDER” Multi system disease – A syndrome Metabolic – endocrine – vascular – –Cardiac – cerebral – renal – Ophthalmic From blood sugar to blood vessel

The Fasted State Only 6 to 8 hours Insulin sensitive tissues –Muscle & adipose tissues Non insulin sensitive tissue –Brain – cannot utilize FFA, depends on glucose Liver mediated –Glycogenolysis 50% –Gluconeogenesis 50% from precursors & FFA

The Fed State To minimize glucose fluctuations. To restore normoglycemia. 1.Suppression of endogenous G-production. 2.Stimulation of hepatic G-uptake. 3.Acceleration of G-uptake by muscle etc.

The Fed State In the liver –Directly by  glucose production –Indirectly by  lipolysis –Glycogen synthesis In the muscle –Glycogen synthesis –Oxidative and non-oxidative metabolism of G In the adipose tissue –Alpha glycero phosphate – esterification of FFA to TG

Prandial Glucose Regulation Diet modification to reduce simple CHO Drugs modifying absorption Short action Insulin around meal Short acting insulin secretagogues Anti Glucagon (Amylin,GLP-1,Pramlnitide) Insulin sensitizers

Insulin Not a mere regulator of blood glucose Has profound effect on all fuels Lipid metabolism Protein metabolism CHO – metabolism –Glucose utilization – muscle & adipose tissue –Gleuconeogenesis & Glycogenolysis

Insulin Delivery Systems Injectable NovoPen, NovoLet. Intra nasal : conc. Preparations, nasal Infl. Intra pulmonary – good abs. Rapid than s/c. Oral insulin – Liposomal envelopes- DU. Islet cell encapsulates – underway.

Elliott P Joslin in 1921 “It is proper at the present time to devote time not alone to treatment but more to prevent diabetes – the results may not be so striking to us immediately, but they are sure to come and to be important.”

Prevention of Diabetes How we have grown ? Prevention holds the key – no users ? Diabetic care is Life long – –Nutrition – Excercise – Education on DM How about NOW – or never ? –1,49, 806 studied – 1 kg  9%  DM risk

Prevention of Diabetes Diets do work Yes you too can–Aerobic exercises – 20mts –50 to 70% of Max capacity x 3 times a week Diet + exercise – 6 times more than OHAs Diabetes preventable – few takers Talk is cheap – it pays Shift focus to adolescence / adult hood

Should we wait ? and Pay heavily on –ICUs, transplant units, amputation units –Laser therapy, physio therapy units Or pay very little now –By preventing the epidemic rise in DM Clinical diabetes – ADA – Apr/June 2001

Insulin Resistance Metabolic syndrome Multi system disorder Predisposes to DM & CVD Contributors to IR 1. Genetic 2. Obesity – abdominal 3. Physical inactivity 4. Advancing age

Insulin Resistance Atherogenic dyslipidemia –  In VLDL,  in small LDL,  in HDL Prothrombotic state –  In fibrinogen levels –  In plasminogen activator inhibitor –Various platelet abnormalities G.T. Abnormalities – IGT, hyper glycemia Hypertension

Evidence for Insulin Resistance Abdominal obesity B.P – High normal or Mild HT TG high normal  250 Lowered HDL  40 for men,  50 women Boarder line LDL mg% IGT -- FPG – mg% Having Diabetes is equivalent to having IHD

Predictors of Worsening of GT Insulin resistance Insulin Secretory dysfunction These can be assessed by –Insulin stimulated glucose disposal (M) –Acute insulin Secretory response (AIR) –Hydrodensitometry (body composition)

Mandatory Examinations H/o Smoking H/o IHD Family H/o DM H/o Hypoglycemia Exam for all pulses B.P recording Foot exam Trophic Autonomic neuropathy Fundus exam for DR Fasting and PP BG GHb A1c periodically Microalbuminuria Lipid profile ACR ECG for LVH, IHD Echo for LV Dysfun. Stress test – ST Seg.

Risk Assessment BMI : (wt /ht 2 )  25 normal –25. To 29.9 over wt,  30 obese Waist size : males  40” (102 cm) obesity –Females  36” (88 cm) obesity – Borderline Waist/hip ratio : abnormal if –  0.8 for women –  0.9 for men

Detection of Clinical & Sub-clinical Cardiovascular Disease in the Diabetics Stress testing (BP & HR response blunted) Painless ST depression, lowered specificity Echo : diastolic dysfunction Tc 99 perfusion Scintigraphy Autonomic dysfunction (50% mort. In 5yrs) LVH in ECG is strong predictor of CHD Coronary calcium scoring - CT based

Albumin Creatinine Ratio (ACR) Early predictor of Nephropathy  in ACR occurs even with in first 5yrs Also for retinopathy First void sample of urine to test Albumin in mg% / Creatinine in m mols –Males normal up to 3.5 –Females normal up to 4.0

Diabetic Retinopathy Type 1 – 71% Type 2 non insulin req. – DR is 37% Type 2 insulin req. – DR is 70 % (Diabetes mellitus type 1 -10%, type % Risk factors –Duration  15yrs, hyperglycemia level –HT. Hyper lipidemia, nephropathy Treatment : VEGF inhibitor, Vit E. Octreotide Photocoagulation

Almighty Pardons and Grants me heaven Even if I don't know a single letter about –Crutz Feld Jacob’s Disease –Tsutsugamushi Fever –Criggler Nazzar Syndrome –South American equine encephalitis and –Many and much more BUT

Almighty Will drag me to hell and will not pardon My ignorance of even the minute details of DM My indifference to apply current knowledge My negligence in screening for DM My despondency about preventing DM My inadequacy in maintaining my patients –As normo-glycemic as possible – (This is applicable to all common diseases)

Do You Who I am ? I am the primary care physician On whom my patients bestow all trust

OUR COMMITMENT